<?xml version="1.0" encoding="UTF-8"?>
<ack>
 <title>Acknowledgements</title>
 <p>The authors thank the clinical investigators, patients, and site personnel who participated in this study. Editorial and medical writing assistance was provided by Jennifer Vanden Burgt, an independent Medical Affairs consultant, Minneapolis, MN and funded by Helsinn Healthcare SA, Lugano, Switzerland.</p>
 <sec>
  <title>Funding</title>
  <p>Helsinn Healthcare, SA, Lugano, Switzerland who provided the study drugs and the funding for this study (no grant number applies). </p>
 </sec>
 <sec>
  <title>Disclosure</title>
  <p>LZ: consultant for MSD; research funding from Helsinn, Lilly, and MSD; SL: consultant for Boehringer and Roche; speaker's bureau for Lilly; travel reimbursed by Hutchison and Medipharm Limited; JC: medical advisor for QuintilesIMS; SC: employee of Helsinn Healthcare; CL: employee of Helsinn Healthcare; KJ: consultant for Helsinn Healthcare, Merck, MSD and Tesaro; travel reimbursed by MSD; MA: consultant/investigator for Helsinn Healthcare, Merck and Tesaro. All remaining authors have declared no conflicts of interest.</p>
 </sec>
</ack>
